Announcements Trials
Browse Landscape

Phase

Phase 4 1

Status

Completed 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

CNS 1

Conditions

Brain Neoplasms 3Seizures 2Pinealoma 1Oligodendroglioma 1Neuroectodermal Tumors, Primitive 1Neuroblastoma 1Meningioma 1Medulloblastoma 1Lymphoma, Large B-Cell, Diffuse 1Gliosarcoma 1Glioma 1Glioblastoma 1Epilepsy 1Ependymoma 1Central Nervous System Neoplasms 1Astrocytoma 1

Interventions

LY3295668 erbumine 2Everolimus 2ziprasidone 1enzalutamide 1clevidipine 1Zolpidem 1Warfarin 1Vecuronium Bromide 1Vancomycin 1Tranexamic Acid 1Tobramycin 1Spironolactone 1Sirolimus 1Sevoflurane 1Sevelamer 1Saline Solution 1Rocuronium 1Propofol 1Piperacillin, Tazobactam Drug Combination 1Pentobarbital 1Oxycodone 1Nitrous Oxide 1Nifedipine 1Nafcillin 1Molindone 1Midazolam 1Methylprednisolone 1Mass Screening 1Lurasidone Hydrochloride 1Lidocaine 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Completed × Epilepsy × Levetiracetam × Clear all
NCT00571155 2009-08-20

Trial of Levetiracetam in Patients With Primary Brain Tumors and Symptomatic Seizures Who Undergo Surgery

University Hospital Tuebingen

Phase 4 Completed
30 enrolled
CNS

Brain Neoplasms, Epilepsy

Data powered by HemOnc (CC BY 4.0) Colophon âš¡